These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Local radiation therapy of B16 melanoma tumors increases the generation of tumor antigen-specific effector cells that traffic to the tumor. Lugade AA; Moran JP; Gerber SA; Rose RC; Frelinger JG; Lord EM J Immunol; 2005 Jun; 174(12):7516-23. PubMed ID: 15944250 [TBL] [Abstract][Full Text] [Related]
6. Heterodimeric IL15 Treatment Enhances Tumor Infiltration, Persistence, and Effector Functions of Adoptively Transferred Tumor-specific T Cells in the Absence of Lymphodepletion. Ng SSM; Nagy BA; Jensen SM; Hu X; Alicea C; Fox BA; Felber BK; Bergamaschi C; Pavlakis GN Clin Cancer Res; 2017 Jun; 23(11):2817-2830. PubMed ID: 27986749 [No Abstract] [Full Text] [Related]
7. Lentivector immunization stimulates potent CD8 T cell responses against melanoma self-antigen tyrosinase-related protein 1 and generates antitumor immunity in mice. Liu Y; Peng Y; Mi M; Guevara-Patino J; Munn DH; Fu N; He Y J Immunol; 2009 May; 182(10):5960-9. PubMed ID: 19414747 [TBL] [Abstract][Full Text] [Related]
8. Adoptive transfer of cytotoxic T lymphocytes targeting two different antigens limits antigen loss and tumor escape. Kaluza KM; Kottke T; Diaz RM; Rommelfanger D; Thompson J; Vile R Hum Gene Ther; 2012 Oct; 23(10):1054-64. PubMed ID: 22734672 [TBL] [Abstract][Full Text] [Related]
9. Self-specific CD8+ T cells maintain a semi-naive state following lymphopenia-induced proliferation. Johnson LD; Jameson SC J Immunol; 2010 May; 184(10):5604-11. PubMed ID: 20393139 [TBL] [Abstract][Full Text] [Related]
10. T cell receptor transgenic lymphocytes infiltrating murine tumors are not induced to express foxp3. Quatromoni JG; Morris LF; Donahue TR; Wang Y; McBride W; Chatila T; Economou JS J Hematol Oncol; 2011 Nov; 4():48. PubMed ID: 22112546 [TBL] [Abstract][Full Text] [Related]
13. Adoptively transferred human lung tumor specific cytotoxic T cells can control autologous tumor growth and shape tumor phenotype in a SCID mouse xenograft model. Oflazoglu E; Elliott M; Takita H; Ferrone S; Henderson RA; Repasky EA J Transl Med; 2007 Jun; 5():29. PubMed ID: 17592641 [TBL] [Abstract][Full Text] [Related]
14. T-cell receptor gene therapy of established tumors in a murine melanoma model. Abad JD; Wrzensinski C; Overwijk W; De Witte MA; Jorritsma A; Hsu C; Gattinoni L; Cohen CJ; Paulos CM; Palmer DC; Haanen JB; Schumacher TN; Rosenberg SA; Restifo NP; Morgan RA J Immunother; 2008 Jan; 31(1):1-6. PubMed ID: 18157006 [TBL] [Abstract][Full Text] [Related]
15. Exploiting in situ antigen generation and immune modulation to enhance chemotherapy response in advanced melanoma: A combination nanomedicine approach. Lu Y; Wang Y; Miao L; Haynes M; Xiang G; Huang L Cancer Lett; 2016 Aug; 379(1):32-8. PubMed ID: 27235608 [TBL] [Abstract][Full Text] [Related]
16. Adoptive cytotoxic T lymphocyte therapy triggers a counter-regulatory immunosuppressive mechanism via recruitment of myeloid-derived suppressor cells. Hosoi A; Matsushita H; Shimizu K; Fujii S; Ueha S; Abe J; Kurachi M; Maekawa R; Matsushima K; Kakimi K Int J Cancer; 2014 Apr; 134(8):1810-22. PubMed ID: 24150772 [TBL] [Abstract][Full Text] [Related]
17. Melanoma-infiltrating dendritic cells induce protective antitumor responses mediated by T cells. Preynat-Seauve O; Contassot E; Schuler P; French LE; Huard B Melanoma Res; 2007 Jun; 17(3):169-76. PubMed ID: 17505262 [TBL] [Abstract][Full Text] [Related]
18. Suppression of T-cell expansion by melanoma is exerted on resting cells. Russ AJ; Wentworth L; Xu K; Rakhmilevich A; Seroogy CM; Sondel PM; Suresh M; Cho CS Ann Surg Oncol; 2011 Dec; 18(13):3848-57. PubMed ID: 21465311 [TBL] [Abstract][Full Text] [Related]
19. Tracking in vivo migration and distribution of antigen-specific cytotoxic T lymphocytes by 5,6-carboxyfluorescein diacetate succinimidyl ester staining during cancer immunotherapy. Xu WL; Li SL; Wen M; Wen JY; Han J; Zhang HZ; Gao F; Cai JH Chin Med J (Engl); 2013 Aug; 126(16):3019-25. PubMed ID: 23981604 [TBL] [Abstract][Full Text] [Related]
20. Type 1 and type 2 CD8+ effector T cell subpopulations promote long-term tumor immunity and protection to progressively growing tumor. Dobrzanski MJ; Reome JB; Dutton RW J Immunol; 2000 Jan; 164(2):916-25. PubMed ID: 10623840 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]